Patients with resected stage 3 or 4 melanoma treated with immune-oncology agents demonstrated significantly higher cure rates compared to those treated with placebo.
Health Professionals
Global research team develops diagnostic model for iris melanoma
Investigators from Bergen, Norway, and Cleveland, Ohio, collaborated on the predictive model
Radioactive iodine for thyroid cancer linked to risk for melanoma, other skin cancers
Patients with primary thyroid cancer who received radioactive iodine therapy had elevated risk for melanoma/skin cancer.
Immunotherapy Combination May Demonstrate Benefit in Patients With Cutaneous Melanoma
Presurgical treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab may improve tumor control in patients with stage III cutaneous melanoma, according to a recent study published by Davar et al in Cancer Cell.